Their findings enhance our understanding of gene regulation during blastoid formation and ... New Drug Tested to Reduce Side Effect of 'Half-Matched' Stem Cell Transplants Dec. 5, 2024 — Stem ...

As part of the deal, PNG has agreed to tighten foreign investment screening and block economically unviable or high-risk projects. Papua New Guinea's government has promised not to push ahead with ...

Cell reprogramming is the process of reverting mature, specialised cells into induced pluripotent stem cells. Reprogramming also refers to the erasure and re-establishment of epigenetic marks ...

Ruxolitinib is a selective inhibitor of JAK1 and JAK2, widely used for the treatment of high- and intermediate-risk DIPSS plus score prognosis of myelofibrosis, with the aim of improving splenomegaly ...

Follicular lymphoma (FL) is a mature lymphoid malignancy derived from germinal center B cells, accounting for approximately 22% of all non-Hodgkin's lymphomas. It is common in middle-aged and older ...